MXPA02012569A - Ftalidas substituidas novedosas, un procedimiento para su preparacion y las composiciones farmaceuticas que contienen a las mismas. - Google Patents

Ftalidas substituidas novedosas, un procedimiento para su preparacion y las composiciones farmaceuticas que contienen a las mismas.

Info

Publication number
MXPA02012569A
MXPA02012569A MXPA02012569A MXPA02012569A MXPA02012569A MX PA02012569 A MXPA02012569 A MX PA02012569A MX PA02012569 A MXPA02012569 A MX PA02012569A MX PA02012569 A MXPA02012569 A MX PA02012569A MX PA02012569 A MXPA02012569 A MX PA02012569A
Authority
MX
Mexico
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
new substituted
substituted phthalides
Prior art date
Application number
MXPA02012569A
Other languages
English (en)
Inventor
Zongru Guo
Original Assignee
Inst Materia Medica
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Materia Medica filed Critical Inst Materia Medica
Publication of MXPA02012569A publication Critical patent/MXPA02012569A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Abstract

La invencion se refiere a los compuestos de la formula (1): en donde R1 representa un grupo de alquilo o ureido, R2 representa un grupo de alquilo o un atomo de hidrogeno, o R1 y R2 juntos forman un anillo de 5- o 6-miembros, R3 representa un grupo CN, NO2, NRaR'a, NRaSO2, R'a, CZR5 o CZNRaR'a, R4 representa un atomo de hidrogeno o un grupo R3.
MXPA02012569A 2000-06-28 2001-06-27 Ftalidas substituidas novedosas, un procedimiento para su preparacion y las composiciones farmaceuticas que contienen a las mismas. MXPA02012569A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNB001193295A CN1182127C (zh) 2000-06-28 2000-06-28 新的取代的2-苯并[c]呋喃酮化合物,其制备方法以及包含它们的药物组合物
PCT/IB2001/001535 WO2002000638A2 (en) 2000-06-28 2001-06-27 Substituted phthalides as anti-convulsive drugs

Publications (1)

Publication Number Publication Date
MXPA02012569A true MXPA02012569A (es) 2004-05-17

Family

ID=4587601

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02012569A MXPA02012569A (es) 2000-06-28 2001-06-27 Ftalidas substituidas novedosas, un procedimiento para su preparacion y las composiciones farmaceuticas que contienen a las mismas.

Country Status (19)

Country Link
US (1) US6689808B2 (es)
EP (1) EP1320528A2 (es)
JP (1) JP2004501909A (es)
KR (1) KR20030024710A (es)
CN (2) CN1182127C (es)
AR (1) AR030239A1 (es)
AU (1) AU2001280004A1 (es)
BR (1) BR0112043A (es)
CA (1) CA2413752A1 (es)
CZ (1) CZ2003245A3 (es)
EA (1) EA200300044A1 (es)
HU (1) HUP0301567A3 (es)
MX (1) MXPA02012569A (es)
NO (1) NO20026154L (es)
NZ (1) NZ523174A (es)
PL (1) PL359373A1 (es)
SK (1) SK1062003A3 (es)
WO (1) WO2002000638A2 (es)
ZA (1) ZA200210004B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004022035D1 (de) 2003-05-14 2009-08-27 Dsm Ip Assets Bv Verwendung von pthalide derivativen zur behandlung
CN100518733C (zh) 2003-09-23 2009-07-29 帝斯曼知识产权资产管理有限公司 用于治疗和预防糖尿病的组合物
CN1605336A (zh) * 2003-10-10 2005-04-13 中国医学科学院药物研究所 左旋丁基苯酞在制备预防和治疗脑梗塞的药物中的应用
JP2008502607A (ja) * 2004-06-18 2008-01-31 石薬集団中奇制薬技術（石家庄）有限公司 痴呆の予防および治療におけるＬ−ｎ−ブチルフタリドの適用
CN106074497A (zh) * 2010-01-13 2016-11-09 石药集团恩必普药业有限公司 丁苯酞及其衍生物在制备治疗帕金森病的药物中的应用
CN102260233A (zh) * 2011-05-04 2011-11-30 武汉科技大学 3-丁基-1(3h)-异苯并呋喃酮衍生物及其制备方法
CN105367526B (zh) * 2015-10-14 2017-07-28 济南诚汇双达化工有限公司 一种高纯度正丁基苯酞的制备方法
CN108727352B (zh) * 2017-04-14 2021-04-23 四川大学 一类哌啶烷氨甲酰基苯酞类化合物、其制备方法和用途
PL3845524T3 (pl) * 2018-03-19 2022-10-24 Henan Genuine Biotech Co., Ltd. Związki kwasu benzoesowego i sposób ich wytwarzania oraz ich zastosowania
CN108752300B (zh) * 2018-05-16 2022-03-25 中国科学院昆明植物研究所 苄烯叉苯肽类化合物及其药物组合物和其应用
CN109111415B (zh) * 2018-10-25 2022-08-23 安徽中医药大学 一类石斛生物碱衍生物、制备方法和医药用途
CN112010827A (zh) * 2019-05-28 2020-12-01 四川大学 一类苄胺基苯酞类化合物、其制备方法和用途
CN112010837B (zh) * 2019-05-28 2021-12-17 四川大学 一类吡啶甲胺基苯酞类化合物、其制备方法和用途
CN110452203B (zh) * 2019-08-29 2021-04-13 忻州师范学院 一种1-氧代-1,3-二氢-3-羟基苯并呋喃-5-甲酸的制备方法
CN112794831B (zh) * 2021-04-06 2021-07-27 北京理工大学 3-(3′-羟基丁基)异苯并呋喃-1(3h)-酮衍生物及其组合物、制备方法和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1183053B (it) * 1984-02-02 1987-10-05 Farmaceutico Ct Lab Derivati dell'alfa-amino-gamma-butirrolatton e, metodo per prepararli e composizioni farmaceutiche che li contengono
DE3615157A1 (de) * 1986-05-05 1987-11-12 Schwabe Willmar Gmbh & Co 5-arylalkyl-4-alkoxy-2(5h)-furanone, zwischenprodukte und verfahren zu ihrer herstellung sowie ihre anwendung als therapeutische wirkstoffe
CA1330613C (en) * 1988-05-06 1994-07-05 Masanori Kawamura Amino acid derivatives
TW270133B (es) * 1993-09-17 1996-02-11 Ciba Geigy
DE19618854A1 (de) * 1996-05-10 1997-11-13 Basf Ag Verfahren zur Herstellung von Phthaliden
DE19626659A1 (de) * 1996-07-03 1998-01-08 Basf Ag Verfahren zur Herstellung von Phthaliden

Also Published As

Publication number Publication date
CN1182127C (zh) 2004-12-29
CA2413752A1 (en) 2002-01-03
AU2001280004A1 (en) 2002-01-08
CZ2003245A3 (cs) 2003-05-14
WO2002000638A2 (en) 2002-01-03
WO2002000638A3 (en) 2002-05-23
AR030239A1 (es) 2003-08-13
WO2002000638A8 (en) 2003-08-28
NZ523174A (en) 2004-06-25
KR20030024710A (ko) 2003-03-26
HUP0301567A3 (en) 2005-08-29
NO20026154D0 (no) 2002-12-20
PL359373A1 (en) 2004-08-23
NO20026154L (no) 2003-02-20
CN1440398A (zh) 2003-09-03
SK1062003A3 (en) 2003-05-02
US6689808B2 (en) 2004-02-10
HUP0301567A2 (hu) 2003-09-29
CN1330069A (zh) 2002-01-09
US20030220393A1 (en) 2003-11-27
EP1320528A2 (en) 2003-06-25
JP2004501909A (ja) 2004-01-22
EA200300044A1 (ru) 2003-06-26
CN100402515C (zh) 2008-07-16
BR0112043A (pt) 2003-10-28
ZA200210004B (en) 2003-12-10

Similar Documents

Publication Publication Date Title
FR2727682B1 (es)
MXPA02012569A (es) Ftalidas substituidas novedosas, un procedimiento para su preparacion y las composiciones farmaceuticas que contienen a las mismas.
TW221811B (es)
MX9709951A (es) Derivados de benzamida y su uso como antagonistas de vasopresina.
ES2154167A1 (es) Aminoderivados ciclicos antagonistas del receptor ccr-3.
MXPA02012033A (es) Derivados de 2-aminocarbonil-9h-purina.
GB0129476D0 (en) Organic compounds
DE69903976D1 (de) Heteroaryl-zyklische acetale
YU52403A (sh) Heterociklična jedinjenja koja imaju antibakterijsko dejstvo, postupak za njihovo dobijanje i farmaceutske smeše koje ih sadrže
TW200738667A (en) Preparation method for dioxan-2-ylalkylcarbamate derivatives and intermediate thereof
AU2267495A (en) Benzamide derivatives as vasopressin antagonists
NZ503912A (en) Piperidinylaminomethyl trifluoromethyl cyclic ether compounds and their use as substance P antagonists
HUP0402033A2 (hu) 2-Amino-4-piridil-metil-tiazolin-származékok alkalmazása az indukálható NO-szintetáz inhibitoraként, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
EP0335979A4 (en) Thienopyrimidine derivatives
HUP9800146A2 (hu) Thalidomidszármazékok, eljárás előállításukra és felhasználásuk
ES2124413T3 (es) Derivados de piridazinona con actividad farmaceutica.
SE9904128D0 (sv) Novel compounds
MXPA05005340A (es) Nuevos derivados antagonistas del receptor de la vitronectina, sus procedimientos de preparacion, su aplicacion como medicamentos y los compuestos farmaceuticos que los contienen.
DK1047664T3 (da) Tricykliske forbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
IL115085A (en) Piperazine bicyclic carboxamide derivatives their preparation and pharmaceutical compositions containing them
DK1351942T3 (da) Nye 2,3-benzodiazepinderivater og farmaceutiske sammensætninger indeholdende disse som den aktive bestanddel
MXPA03002532A (es) Nuevos compuestos de indolina, un proceso para su preparacion y composiciones farmaceuticas que los contienen.
ES8304098A1 (es) Un procedimiento para la preparacion de nuevos derivados de dibenzoxazonina, dibenzoxazelina o dibenzooxaazacicloundeca-no y sus correspondientes derivados tia y aza.
YU82302A (sh) Derivati 2-aminokarbonil-9h-purina
TR199901394T2 (xx) NMDA antagonistleri haz�rlanmas� i�in i�lem